FDA Clearance Tracker · P960009-S514
Activa Deep Brain Stimulation Therapy System
Last checked: Nov 20, 2026Latest source record: Dec 17, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 17, 2025
Approved
Time to decision
149 days
Received Jul 21, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P960009-S514
- Device name
- Activa Deep Brain Stimulation Therapy System
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Jul 21, 2025
- Decided
- Dec 17, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for using real-world evidence (RWE) from the Medtronic Registry for Epilepsy (MORE registry) as an alternative approach for the Epilepsy Post- Approval Study (EPAS study, P960009/S433) to meet the conditions of approval outlined in the FDA approval order for P960009/S219
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.